NMRA stock falls after its experimental depression treatment failed to meet the primary and secondary endpoints in the first of three late-stage studies.

Irish music is on a roll, with Fontaines DC on the brink of playing stadiums and acts such as Lankum and NewDad putting a new twist on folk balladry and wispy indie rock. But if they are today’s stars ...

Neumora Therapeutics' lead candidate, navacaprant, failed to meet primary and secondary endpoints in its Phase 3 KOASTAL-1 ...

Neumora Therapeutics (NMRA) announced results from the Phase 3 KOASTAL-1 Study of navacaprant for the treatment of major depressive disorder. The KOASTAL-1 Study is the first of three replicate Phase ...

Clair De Lune is an improving filly who could open Murphy's account with a win in the first race, while in the Grade 2 ...

Read more on Royals Step Out Today - One Stripe To Be King! on Sporting Post, bringing you the latest in Horse Racing News, Previews and Reviews.

The KOASTAL-1 study enrolled 383 adult patients with MDD. Navacaprant was shown to be safe and generally well-tolerated with ...

Read more on Five For Fourie As Hollywoodbets Punters' Challenge Players Strike Gold on Sporting Post, bringing you the ...

Neumora Therapeutics announced that its antidepressant candidate, navacaprant, did not meet the primary endpoint in a Phase 3 study for major depressive disorder.

Watertown, Massachusetts Friday, January 3, 2025, 18:00 Hrs [IST] ...

Blues chief executive Scott Booth has sought to clarify the club's position ahead of Saturday's trip to Bamber Bridge and an important meeting with North Yorkshire Council.

L’Ormarins King’s Plate weight-for-age Grade 1 has attracted a suitably aristocratic class field of 13 runners.